Fragile X syndrome, the most commonly known single-gene cause of autism, is also linked to dysregulation of mGluR5 signaling, and pharmacological mGluR5 antagonists have demonstrated promising effects in preclinical and early clinical studies51,52. This evidence concerns the gene GRM5 and fragile X syndrome.